Price Chart

Profile

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
URL https://www.zoetis.com
Investor Relations URL https://investor.zoetis.com
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Large Cap/Growth
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 13, 2024
Next Ex-Dividend Date Apr. 18, 2024
Last Ex-Dividend Date Jan. 18, 2024

Profile

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
URL https://www.zoetis.com
Investor Relations URL https://investor.zoetis.com
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Large Cap/Growth
Next Earnings Release May. 03, 2024 (est.)
Last Earnings Release Feb. 13, 2024
Next Ex-Dividend Date Apr. 18, 2024
Last Ex-Dividend Date Jan. 18, 2024